QR Kodea

Sofosbuvir’s hepatoprotective efficacy in rats is enhanced by encapsulating in taurocholate-stabilized galactose-anchored bilosomes

Abstract Background In conjunction with other antiviral medicines, sofosbuvir (SOF) is an essential therapy for chronic hepatitis C. There is some debate over its influence on hepatic fibrosis. The use of nanotechnology in treatment has gained popularity, with the goal of delivering therapeutic subs...

Deskribapen osoa

Gorde:
Egile Nagusiak: Marwa Khaled Mohsen, Soheir Abo El azm Diab, Amani N. Shafik, Ahmed H. Osman, Marianne J. Naguib, Amira M. Kamel, Marwa Nagi Mehesen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SpringerOpen 2025-02-01
Saila:Future Journal of Pharmaceutical Sciences
Gaiak:
Bilosomal formulation
Galactose
Taurocholate
Hepatic fibrosis
Sofosbuvir
Thioacetamide
Sarrera elektronikoa:https://doi.org/10.1186/s43094-025-00775-w
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak